Related references
Note: Only part of the references are listed.Possible link between higher ammonia levels, non-alcoholic fatty liver-related cirrhosis and diabetes: Are we missing chronic disease?
Mohamed A. Elfeki et al.
JOURNAL OF HEPATOLOGY (2023)
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
Angela Rojas et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)
Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease
Katharina Staufer et al.
JOURNAL OF HEPATOLOGY (2022)
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
Rocio Gallego-Duran et al.
SCIENTIFIC REPORTS (2022)
Global multi-stakeholder endorsement of the MAFLD definition
Nahum Mendez-Sanchez et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen
Ruben Rodriguez-Agudo et al.
ANTIOXIDANTS (2022)
A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice
Pinar Gokcen et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2021)
Spatio-Temporal Multiscale Analysis of Western Diet-Fed Mice Reveals a Translationally Relevant Sequence of Events during NAFLD Progression
Ahmed Ghallab et al.
CELLS (2021)
Ammonia Scavenging Prevents Progression of Fibrosis in Experimental Nonalcoholic Fatty Liver Disease
Francesco De Chiara et al.
HEPATOLOGY (2020)
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
Jorge Simon et al.
CELL METABOLISM (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease
Thomas G. Cotter et al.
GASTROENTEROLOGY (2020)
Sexual Dimorphism in Energy Metabolism of Wistar Rats Using Data Analysis
Andrea Leskanicova et al.
MOLECULES (2020)
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron-Wisnewsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression
Kuo Du et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial
Ji Yao Wang et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion
Peter Lykke Eriksen et al.
LIVER INTERNATIONAL (2019)
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)
Sara Montagnese et al.
DIGESTIVE AND LIVER DISEASE (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
An engineered E-coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans
Caroline B. Kurtz et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study
Jeremy F. L. Cobbold et al.
HEPATOLOGY RESEARCH (2018)
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells
Kuo Du et al.
GASTROENTEROLOGY (2018)
Urea cycle dysregulation in non-alcoholic fatty liver disease
Francesco De Chiara et al.
JOURNAL OF HEPATOLOGY (2018)
Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis
Karen Louise Thomsen et al.
MEDICAL HYPOTHESES (2018)
The Pharmabiotic Approach to Treat Hyperammonemia
Jing Liu et al.
NUTRIENTS (2018)
Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells
Kelly J. Peyton et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot
Ahmed Abdel-Razik et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)
A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans
David G. Levitt et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2018)
Pivotal Role of Glutamine Synthetase in Ammonia Detoxification
Theodorus B. M. Hakvoort et al.
HEPATOLOGY (2017)
Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice
Cathrin Sellmann et al.
JOURNAL OF NUTRITION (2017)
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
Kosuke Kaji et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction
Wei-Wei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
A morphological method for ammonia detection in liver
Virginia Gutierrez-de-Juan et al.
PLOS ONE (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
Venkatanarayana Gangarapu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Engineering the gut rnicrobiota to treat hyperammonemia
Ting-Chin David Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis
Cathrin Sellmann et al.
JOURNAL OF NUTRITION (2015)
Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy
Nan Yang et al.
NEURAL REGENERATION RESEARCH (2015)
Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase
Natalia Qvartskhava et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial
Venigalla Pratap Mouli et al.
HEPATOLOGY RESEARCH (2015)
Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function
Karen Louise Thomsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial
Manish Kumar Lunia et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats
M. Jover-Cobos et al.
JOURNAL OF HEPATOLOGY (2014)
Effects of glutamine on oxidative stress and nuclear factor-κB expression in the livers of rats with nonalcoholic fatty liver disease
Zhihui Lin et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids
Anthony J. Richardson et al.
BMC MICROBIOLOGY (2013)
Glutaminase Isoenzymes as Key Regulators in Metabolic and Oxidative Stress Against Cancer
J.M. Mates et al.
CURRENT MOLECULAR MEDICINE (2013)
Glutamine synthetase expression in activated hepatocyte progenitor cells and loss of hepatocellular expression in congestion and cirrhosis
Kirsten E. Fleming et al.
LIVER INTERNATIONAL (2013)
Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy
Vicente Felipo et al.
METABOLIC BRAIN DISEASE (2012)
Ammonia toxicity and its prevention in inherited defects of the urea cycle
V. Walker
DIABETES OBESITY & METABOLISM (2009)
Identifying the direct effects of ammonia on the brain
Cristina R. Bosoi et al.
METABOLIC BRAIN DISEASE (2009)
Methionine metabolism and liver disease
Jose M. Mato et al.
ANNUAL REVIEW OF NUTRITION (2008)
L-Ornithine phenylacetate (OP): A novel treatment for hyperammonemia and hepatic encephalopathy
R. Jalan et al.
MEDICAL HYPOTHESES (2007)
Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model
Jian-Gao Fan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Probiotics can treat hepatic encephalopathy
SF Solga
MEDICAL HYPOTHESES (2003)
Mechanisms governing the expression of the enzymes of glutamine metabolism - Glutaminase and glutamine synthetase
BI Labow et al.
JOURNAL OF NUTRITION (2001)
Glutamine and glutamate metabolism across the liver sinusoid
M Watford
JOURNAL OF NUTRITION (2000)
Share Paper
